Pachyonychia congenita and hidradenitis suppurativa: no response to infliximab therapy

Author(s):  
J Pedraz ◽  
PF Peñas ◽  
A Garcia-Diez
2021 ◽  
Vol 141 (10) ◽  
pp. S176
Author(s):  
M. Pavlovsky ◽  
A. Peled ◽  
O. Sarig ◽  
N. Astman ◽  
L. Malki ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-13 ◽  
Author(s):  
Müzeyyen Gönül ◽  
Bengu Cevirgen Cemil ◽  
Havva Ozge Keseroglu ◽  
Havva Kaya Akis

Many advances in dermatology have been made in recent years. In the present review article, newly described disorders from the last six years are presented in detail. We divided these reports into different sections, including syndromes, autoinflammatory diseases, tumors, and unclassified disease. Syndromes included are “circumferential skin creases Kunze type” and “unusual type of pachyonychia congenita or a new syndrome”; autoinflammatory diseases include “chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome,” “pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome,” and “pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH) syndrome”; tumors include “acquired reactive digital fibroma,” “onychocytic matricoma and onychocytic carcinoma,” “infundibulocystic nail bed squamous cell carcinoma,” and “acral histiocytic nodules”; unclassified disorders include “saurian papulosis,” “symmetrical acrokeratoderma,” “confetti-like macular atrophy,” and “skin spicules,” “erythema papulosa semicircularis recidivans.”


1990 ◽  
Vol 123 (5) ◽  
pp. 663-666 ◽  
Author(s):  
P. TODD ◽  
J. GARIOCH ◽  
M. RADEMAKER ◽  
W. SUSSKIND ◽  
C. GEMELL ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document